The stimulation with an Arg-1- derived peptide (ArgLong2, 38-mer, positions 169–206 in Arg-1) in vitro, strongly impacted responses against Arg-1 in healthy donors and cancer patients, rebalancing the microenvironment [108]. The gene discussed is ARG1; the disease is cancer.